Prosthetic Heart Valves Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Prosthetic Heart Valves Market Report Overview
The prosthetic heart valves market size was valued at $2.15 billion in 2023. The prosthetic heart valves market will grow at a CAGR of more than 3% from 2023 to 2033. The growing aging population across the globe and the associated valvular degeneration is primarily driving the prosthetic heart valve market growth.
Prosthetic Heart Valves Market Outlook 2023-2033 ($ Billion)
Buy the Full Report for More Insights on the Prosthetic Heart Valves Market Forecast, Download a Free Sample Report
The prosthetic heart valves market research report explains the market behavior to help identify market trends within cardiovascular devices therapeutic areas. The report has extensively covered regional-wise quantitative data, highlighting the number of prosthetic heart valves across labs, which will help in identifying untapped market opportunities. The prosthetic heart valves market model also discusses the detailed impact of COVID-19 on the prosthetic heart valves market for 2020 and beyond.
Market Size (2023) | $2.15 billion |
CAGR (2023-2033) | >3% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Prosthetic Heart Valves Market Dynamics
With the increasing burden of an aging population and an increase in the associated valvular diseases, especially aortic valve stenosis, the number of tissue valve replacement procedures has increased. The availability of minimally invasive alternatives to TAVR in the form of tissue sutureless aortic valves has bolstered the tissue heart valves market. Furthermore, due to the success of the tissue sutureless aortic valve, there is a growing interest in tissue sutureless mitral valves. While the decline in rheumatic fever cases has reduced the prevalence of valve diseases in the younger population, the increase in the aging population across the world is driving the prosthetic heart valve market growth.
Buy the Full Report for Additional Prosthetic heart valves Market Dynamics, Download a Free Sample Report
Prosthetic Heart Valves Market Segments
The key segments in the prosthetic heart valves market are mechanical heart valves and tissue heart valves. In 2023, the tissue heart valves segment dominated the market share. The segment will further be categorized into tissue sutured aortic valve replacements, tissue sutured mitral valve replacements, and tissue sutureless aortic valve replacements. Of these, the tissue sutured aortic valve replacements led the market share in 2023.
Prosthetic Heart Valves Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment-Wise Insights in the Prosthetic Heart Valves Market, Download a Free Sample Report
Prosthetic Heart Valves Market Segmentation by Regions
The key regions in the prosthetic heart valves market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America led the market share and continue to dominate the market growth during the projected period.
The US, Canada, and Mexico will experience growth in their number of prosthetic heart valve replacements during the forecast period. These changes are expected to align with trends in the aging population and associated degenerative valvular conditions. The increasing use of transcatheter aortic valve replacement and declining incidence of rheumatic fever will slow the overall growth. However the increasing use of tissue valves, especially tissue sutureless aortic valves, will drive the market.
Prosthetic Heart Valves Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights in the Prosthetic Heart Valves Market, Download A Free Sample Report
Prosthetic Heart Valves Market – Competitive Landscape
The key companies in the prosthetic heart valves market are Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, and Braile Biomedica Ltd among others. In 2023, Edwards Lifesciences Corp accounted for the highest prosthetic heart valves market share and value.
Prosthetic Heart Valves Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the Prosthetic Heart Valves Market, Download a Free Sample Report
Segments Covered in this Report
Prosthetic Heart Valves Segment Outlook ($ Million, 2015-2033)
- Mechanical Heart Valves
- Mechanical Sutured Aortic Valve Replacements
- Mechanical Sutured Mitral Valve Replacements
- Tissue Heart Valves
- Tissue Sutured Aortic Valve Replacements
- Tissue Sutured Mitral Valve Replacements
- Tissue Sutureless Aortic Valve Replacements
Prosthetic heart valves Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
Currently marketed prosthetic heart valves market and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Prosthetic heart valves market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Prosthetic heart valves market.
- Competitive dynamics insights and trends provided for the prosthetic heart valves market.
Get an in-depth understanding of the consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, Braile Biomedica Ltda, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. The model will benefit the following stakeholders:
- CMO executives who must have a deep understanding of the prosthetic heart valves marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on prosthetic heart valves.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving prosthetic heart valves.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the prosthetic heart valves market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific prosthetic heart valves market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Abbott Laboratories
Medtronic Plc
Corcym UK Ltd
Artivion Inc
Lepu Medical Technology (Beijing) Co Ltd
TTK Healthcare Ltd
Braile Biomedica Ltda
Others
Frequently asked questions
-
What was the prosthetic heart valves market size in 2023?
The prosthetic heart valves market size was $2.15 billion in 2023.
-
What will the CAGR of the prosthetic heart valves market be during 2023-2033?
The prosthetic heart valves will grow at a CAGR of more than 3% during 2023-2033.
-
Which was the leading segment in the prosthetic heart valves market in 2023?
Tissue heart valves segment was leading the prosthetic heart valves market in 2023.
-
Which region held the largest share of the prosthetic heart valves market?
North America was the largest regional market for prosthetic heart valves in 2023.
-
Which are the leading players in the prosthetic heart valves market?
The key companies in the prosthetic heart valves market are Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, Braile Biomedica Ltda, and Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.